Terms: = Lymphoma AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA AND Prognosis
15 results:
1. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
2. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
3. m6A-Regulator Expression Signatures Identify a Subset of Follicular lymphoma Harboring an Exhausted Tumor Microenvironment.
Zhang T; Liu H; Gao F; Gong W; Cui Y; He J; Li L; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Zhang H; Wang X
Front Immunol; 2022; 13():922471. PubMed ID: 35734168
[TBL] [Abstract] [Full Text] [Related]
4. SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups.
Guo B; Huang Y; Duan Y; Liao C; Cen H
Cancer Med; 2022 Mar; 11(5):1281-1291. PubMed ID: 35106936
[TBL] [Abstract] [Full Text] [Related]
5. Frequent mutated B2M, EZH2, IRF8, and tnfrsf14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.
de Groen RAL; van Eijk R; Böhringer S; van Wezel T; Raghoo R; Ruano D; Jansen PM; Briaire-de Bruijn I; de Groot FA; Kleiverda K; Te Boome L; Terpstra V; Levenga H; Nicolae A; Posthuma EFM; Focke-Snieders I; Hardi L; den Hartog WCE; Bohmer LH; Hogendoorn PCW; van den Berg A; Diepstra A; Nijland M; Lugtenburg PJ; Kersten MJ; Pals ST; Veelken H; Bovée JVMG; Cleven AHG; Vermaat JSP
Blood Adv; 2021 Oct; 5(19):3760-3775. PubMed ID: 34478526
[TBL] [Abstract] [Full Text] [Related]
6. c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.
Bouroumeau A; Bussot L; Bonnefoix T; Fournier C; Chapusot C; Casasnovas O; Martin L; McLeer A; Col E; David-Boudet L; Lefebvre C; Algrin C; Raskovalova T; Jacob MC; Vettier C; Chevalier S; Callanan MB; Gressin R; Emadali A; Sartelet H
J Pathol Clin Res; 2021 Nov; 7(6):604-615. PubMed ID: 34374220
[TBL] [Abstract] [Full Text] [Related]
7. Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.
Chaudhary S; Brown N; Song JY; Yang L; Skrabek P; Nasr MR; Wong JT; Bedell V; Murata-Collins J; Kochan L; Li J; Zhang W; Chan WC; Weisenburger DD; Perry AM
Hum Pathol; 2021 Aug; 114():19-27. PubMed ID: 33964277
[TBL] [Abstract] [Full Text] [Related]
8. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract] [Full Text] [Related]
9. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia.
Kang SH; Hwang HJ; Yoo JW; Kim H; Choi ES; Hwang SH; Cho YU; Jang S; Park CJ; Im HJ; Seo JJ; Kim N; Koh KN
Anticancer Res; 2019 Oct; 39(10):5531-5539. PubMed ID: 31570447
[TBL] [Abstract] [Full Text] [Related]
10. High tnfrsf14 and low BTLA are associated with poor prognosis in Follicular lymphoma and in Diffuse Large B-cell lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract] [Full Text] [Related]
11. Concomitant 1p36 deletion and tnfrsf14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract] [Full Text] [Related]
12. Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma.
Adams HJA; de Klerk JMH; Fijnheer R; Heggelman BGF; Dubois SV; Nievelstein RAJ; Kwee TC
Eur J Radiol; 2016 Jan; 85(1):304-309. PubMed ID: 26515992
[TBL] [Abstract] [Full Text] [Related]
13. Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764).
Joyce MJ; Pollock BH; Devidas M; Buchanan GR; Camitta B
J Pediatr Hematol Oncol; 2013 Jan; 35(1):32-5. PubMed ID: 23211688
[TBL] [Abstract] [Full Text] [Related]
14. Acquired tnfrsf14 mutations in follicular lymphoma are associated with worse prognosis.
Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
[TBL] [Abstract] [Full Text] [Related]
15. Stimulation of non-Hodgkin's lymphoma via hvem: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity.
Costello RT; Mallet F; Barbarat B; Schiano De Colella JM; Sainty D; Sweet RW; Truneh A; Olive D
Leukemia; 2003 Dec; 17(12):2500-7. PubMed ID: 14562115
[TBL] [Abstract] [Full Text] [Related]
